It is encouraging, although not surprising, to see that four of the seven cytokines and chemokines identified in the present study (i.e., IL-1B, IL-6, TNF, CCL2) were shown to reflect CCM disease activities in a study on plasma biomarkers [35, 36]. This evidence concerns the gene CCL2 and cerebral cavernous malformation.